Abstract
Purpose
Rheumatoid arthritis (RA) is associated with extra-articular features (ExRA) and other co-morbidities. The aim of this study is to quantify their relative contribution to quality of life (QOL) in patients with RA.
Methods
A consecutive series of 114 ambulatory RA patients aged between 40 and 65 years were assessed by a research nurse on a single occasion. Assessment included a patient questionnaire (including EQ-5D), medication review and fasting venous blood sample. Medical records were reviewed by a rheumatologist for co-existing conditions. Multiple linear regression was used to adjust mean differences in EQ-5D in the presence/absence of co-existing conditions for age, sex, university education, arthritis duration, rheumatoid factor, erythrocyte sedimentation rate, current disease-modifying drug therapy, previous hand joint erosions and joint surgery.
Results
Mean age was 54 years (82 % female) and median arthritis duration 10 years. Unadjusted EQ-5D was −0.09 (95 % CI −0.18 to −0.01) lower in patients with any co-existing condition. EQ-5D scores were inversely correlated with the overall number of co-existing conditions (Spearman’s ρ −0.31, p = 0.001), number of co-morbidities (ρ −0.22, p = 0.02) and number of ExRA features (ρ −0.22, p = 0.02). There was a linear trend of lower EQ-5D with increasing number of co-existing conditions (p = 0.003). EQ-5D was −0.18 (95 % CI −0.33 to −0.02) lower in the presence of more than two co-existing conditions compared to none. Co-morbidity and ExRA features were associated with comparable adjusted reductions (−0.05 vs. −0.06) in EQ-5D scores.
Conclusion
A wide range of co-existing conditions are associated with poorer QOL in patients with RA.
Similar content being viewed by others
Abbreviations
- CI:
-
Confidence interval
- DMARD:
-
Disease-modifying anti-rheumatic drug
- EQ-5D:
-
EuroQOL
- ExRA:
-
Extra-articular features of rheumatoid arthritis
- MCID:
-
Minimal clinically important difference
- MLR:
-
Multiple linear regression
- QOL:
-
Quality of life
- RA:
-
Rheumatoid arthritis
- RAAIX:
-
‘Rheumatoid Arthritis Augmentation Index’ study
- SD:
-
Standard deviation
References
Guthrie, B., Payne, K., Alderson, P., McMurdo, M. E., & Mercer, S. W. (2012). Adapting clinical guidelines to take account of multimorbidity. BMJ, 345, e6341. doi:10.1136/bmj.e6341.
Huntley, A. L., Johnson, R., Purdy, S., Valderas, J. M., & Salisbury, C. (2012). Measures of multimorbidity and morbidity burden for use in primary care and community settings: A systematic review and guide. The Annals of Family Medicine, 10, 134–141.
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012). Epidemiology of multimorbidity and implications for health care, research, and medical education, a cross-sectional study. Lancet, 380, 37–43.
Diederichs, C., Berger, K., & Bartels, D. B. (2011). The measurement of multiple chronic diseases—a systematic review on existing multimorbidity indices. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 66, 301–311.
Prete, M., Racanelli, V., Digiglio, L., Vacca, A., Dammacco, F., & Perosa, F. (2011). Extra-articular manifestations of rheumatoid arthritis: An update. Autoimmunity Reviews, 11, 123–131.
Turesson, C., Jacobsson, L., & Bergstrom, U. (1999). Extra-articular rheumatoid arthritis, prevalence and mortality. Rheumatology, 38, 668–674.
Turesson, C., O’Fallon, W. M., Crowson, C. S., Gabriel, S. E., & Matteson, E. L. (2002). Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. The Journal of Rheumatology, 29, 62–67.
Turesson, C., McClelland, R. L., Christianson, T. J., & Matteson, E. L. (2006). Multiple extra-articular manifestations are associated with poor survival in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 65, 1533–1534.
Avina-Zubieta, J. A., Choi, H. K., Sadatsafavi, M., Etminan, M., Esdaile, J. M., & Lacaille, D. (2008). Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Care & Research, 59, 1690–1697.
Sharabiani, M. T., Aylin, P., & Bottle, A. (2012). Systematic review of comorbidity indices for administrative data. Medical Care, 50, 1109–1118.
Haroon, N., Aggarwal, A., Lawrence, A., Agarwal, V., & Misra, R. (2007). Impact of rheumatoid arthritis on quality of life. Modern Rheumatology, 17, 290–295.
Bedi, G. S., Gupta, N., Handa, R., Pal, H., & Pandey, R. M. (2005). Quality of life in Indian patients with rheumatoid arthritis. Quality of Life Research, 14, 1953–1958.
Eser, F., Garip, Y., & Bodur, H. (2012). Extraarticular manifestations in Turkish patients with rheumatoid arthritis, impact of EAMs on the health-related quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning. Rheumatology International, 32, 1521–1525.
Lee, T. J., Park, B. H., Son, H. K., et al. (2012). Cost of illness and quality of life of patients with rheumatoid arthritis in South Korea. Value in Health, 15, S43–S49.
Wolfe, F., Michaud, K., Li, T., & Katz, R. S. (2010). Chronic conditions and health problems in rheumatic diseases, comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia. The Journal of Rheumatology, 37, 305–315.
Salaffi, F., Carotti, M., Ciapetti, A., Gasparini, S., & Grassi, W. (2011). A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology, 29, 661–671.
Radner, H., Smolen, J. S., & Aletaha, D. (2011). Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Rheumatology, 50, 381–388.
Rupp, I., Boshuizen, H. C., Jacobi, C. E., Dinant, H. J., & van den Bos, G. (2004). Comorbidity in patients with rheumatoid arthritis: Effect on health-related quality of life. The Journal of Rheumatology, 31, 58–65.
Crilly, M. A., Kumar, V., Clark, H. J., Scott, N. W., Macdonald, A. G., & Williams, D. J. (2009). Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: A dose-response relationship independent of established cardiovascular risk factors. Rheumatology, 48, 1606–1612.
The EuroQol Group. (1990). EuroQol: A new facility for the measurement of health-related quality of life. Health Policy, 16, 199–208.
Kind, P., Dolan, P., Gudex, C., & Williams, A. (1998). Variations in population health status: Results from a United Kingdom national questionnaire survey. BMJ, 316, 736–741.
Dolan, P., Gudex, C., Kind, P., & Williams, A. (1995). A social tariff for EuroQol, results from a UK general population survey. Centre For Health Economics. York: University of York. (Discussion Paper 138).
Hurst, N. P., Kind, P., Ruta, D., Hunter, M., & Stubbings, A. (1997). Measuring health-related quality of life in rheumatoid arthritis: Validity, responsiveness and reliability of EuroQol (EQ-5D). Rheumatology, 36, 551–559.
Marra, C. A., Woolcott, J. C., Kopec, J. A., et al. (2005). A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science and Medicine, 60, 1571–1582.
Harrison, M. J., Davies, L. M., Bansback, N. J., Ingram, M., Anis, A. H., & Symmons, D. P. (2008). The validity and responsiveness of generic utility measures in rheumatoid arthritis: A review. The Journal of Rheumatology, 35, 592–602.
Linde, L., Sorensen, J., Ostergaard, M., Horslev-Petersen, K., & Hetland, M. L. (2008). Health-related quality of life, validity, reliability, and responsiveness of SF-36, 15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis. The Journal of Rheumatology, 35, 1528–1537.
Meijer, J. M., Meiners, P. M., Huddleston-Slater, J. J., et al. (2009). Health-related quality of life, employment and disability in patients with Sjogren’s syndrome. Rheumatology, 48, 1077–1082.
Atroshi, I., Gummesson, C., McCabe, S. J., & Ornstein, E. (2007). The SF-6D health utility index in carpal tunnel syndrome. Journal of Hand Surgery European, 32, 198–202.
Panoulas, V. F., Douglas, K. M., Milionis, H. J., et al. (2007). Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology, 46, 1477–1482.
Carmona, L., Gonzalez-Alvaro, I., Balsa, A., Angel, B. M., Tena, X., & Sanmarti, R. (2003). Rheumatoid arthritis in Spain: Occurrence of extra-articular manifestations and estimates of disease severity. Annals of the Rheumatic Diseases, 62, 897–900.
Turesson, C., McClelland, R. L., Christianson, T., & Matteson, E. (2008). Clustering of extraarticular manifestations in patients with rheumatoid arthritis. The Journal of Rheumatology, 35, 179–180.
Young, A., & Koduri, G. (2007). Extra-articular manifestations and complications of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology, 21, 907–927.
Panoulas, V. F., Metsios, G. S., Pace, A. V., et al. (2008). Hypertension in rheumatoid arthritis. Rheumatology, 47, 1286–1298.
Palm, O., Garen, T., Enger, T. B., et al. (2008). Clinical pulmonary involvement in primary Sjogren’s syndrome: Prevalence, quality of life and mortality—a retrospective study based on registry data. Rheumatology, 52, 173–179.
Norton, S., Koduri, G., Nikiphorou, E., et al. (2013). A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology, 52, 99–110.
Acknowledgments
The study was funded from a charitable source (NHS Grampian Rheumatology Endowments).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Crilly, M.A., Johnston, M.C. & Black, C. Relationship of EQ-5D quality of life with the presence of co-morbidity and extra-articular features in patients with rheumatoid arthritis. Qual Life Res 23, 1435–1443 (2014). https://doi.org/10.1007/s11136-013-0597-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-013-0597-0